Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke
about
The role of the ubiquitin proteasome system in cerebellar development and medulloblastomaThe role of aberrant proteolysis in lymphomagenesisFisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathwayIKKβ links vascular inflammation to obesity and atherosclerosisA covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination.Regulation and Role of EZH2 in CancerYC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERKEctopic expression of nolz-1 in neural progenitors promotes cell cycle exit/premature neuronal differentiation accompanying with abnormal apoptosis in the developing mouse telencephalon.Downregulation of DAB2IP promotes mesenchymal-to-neuroepithelial transition and neuronal differentiation of human mesenchymal stem cells.Epigenetic mechanisms of neuroplasticity and the implications for stroke recovery.PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression.The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial-mesenchymal transition in a sumoylation-regulated manner.Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer developmentRoles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis.The potential roles of EZH2 in regenerative medicine.Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.Ubiquitin Ligases and Deubiquitinating Enzymes in CD4+ T Cell Effector Fate Choice and Function.Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?Praja1 E3 ubiquitin ligase promotes skeletal myogenesis through degradation of EZH2 upon p38α activation.BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells.Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer.Decreased Methylation Level of H3K27me3 Increases Seizure Susceptibility.ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation.P38α/JNK signaling restrains erythropoiesis by suppressing Ezh2-mediated epigenetic silencing of BimUbiquitin Regulation: The Histone Modifying Enzyme's StorySmurfs in Protein Homeostasis, Signaling, and Cancer
P2860
Q26782159-26735153-9FCF-4D1D-AE23-56CE1EF41479Q28084404-2A3D0C3E-3ACD-4166-AD92-22CA1FB15868Q28386841-07067840-BF30-46B8-9EAC-DD55C7E0158DQ33569809-B730B7E0-5BAB-4FB2-897A-8D29F07C412CQ33626131-95AEDA71-2C5F-43AC-8FA4-3419F57A8CC4Q34043370-F04DA5C8-0032-407B-9BEE-005702D361DBQ34571374-083B9583-86FE-4777-BF0F-2354E69C95BDQ35000746-1C5B94BB-9F57-4B41-8D19-39BD21185EE6Q35000947-EF35DF67-40DB-44C9-8181-030B4C2AFC9FQ35220512-EC609255-DF3D-4810-B6D7-45972D802652Q35476750-838D116C-3DF4-4918-B387-FB41BE18242FQ36799312-E8C35C0C-60F5-421D-8F2C-717F64043CB6Q37545071-5846392D-BD54-47CE-9D7A-6C50E99F9A88Q38185265-BA80B72F-7C69-4D4A-8B2F-AE1C584AC60DQ38342509-CA62EFD5-E718-47A7-A6C4-9F1786C700ABQ38594002-9C96ADBF-5CCF-4A77-B40E-DC1C0DC8EC3FQ38665185-4135C461-4F31-47C8-93D5-2727CFE4E087Q38729916-9128A5F8-220B-4DFD-840F-7CB3E143B168Q38835389-CCDEE8AE-4915-4F97-989C-6CBF7FC734D0Q38916628-D54F0929-DEC3-4DC6-945E-AA9F7F5A2D16Q42282686-30A188C6-349D-493E-B598-A76C01B73E5FQ42540751-7EE3AB52-A865-490E-B6F3-AF18D4F96DA9Q46629789-9C196F43-09C8-4DCD-B709-F1E79243D687Q48325256-7DCD5FAF-F4B9-4D55-8AE6-DAAD8D4911D8Q51343136-1B4A187B-3AF7-4565-BED8-640905BF3604Q52718548-BEE9C202-B909-443E-B415-465740E8F8F4Q54381671-6627BE88-6705-45D8-B2D5-0420733F5CADQ58695531-0E97E3C2-3972-44F2-A76A-D525E0FFBFD5Q58700177-A7F57E7F-2BA5-4EC3-B776-DD2C146EAD1DQ58803474-F8DBB08A-4ECA-40CC-8B9B-BB0E226D9A03
P2860
Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Smurf2-mediated degradation of ...... ecovery after ischaemic stroke
@ast
Smurf2-mediated degradation of ...... ecovery after ischaemic stroke
@en
type
label
Smurf2-mediated degradation of ...... ecovery after ischaemic stroke
@ast
Smurf2-mediated degradation of ...... ecovery after ischaemic stroke
@en
prefLabel
Smurf2-mediated degradation of ...... ecovery after ischaemic stroke
@ast
Smurf2-mediated degradation of ...... ecovery after ischaemic stroke
@en
P2093
P2860
P356
P1476
Smurf2-mediated degradation of ...... ecovery after ischaemic stroke
@en
P2093
Chen-Shiou Wu
Cheng-Chieh Yang
Jennifer L Hsu
Jia-Ni Chen
Mien-Chie Hung
Shih-Chieh Hung
Shu-Ching Hsieh
Shu-Ya Chiang
Su-Peng Yeh
P2860
P304
P356
10.1002/EMMM.201201783
P577
2013-03-25T00:00:00Z